Macrophages of human first trimester decidua express markers associated to alternative activation

被引:74
作者
Cupurdija, K
Azzola, D
Hainz, U
Gratchev, A
Heitger, A
Takikawa, O
Goerdt, S
Wintersteiger, R
Dohr, G
Sedlmayr, P
机构
[1] Karl Franzens Univ Graz, Inst Histol & Embryol, A-8010 Graz, Austria
[2] Karl Franzens Univ Graz, Inst Pharmaceut Chem & Pharmaceut Technol, A-8010 Graz, Austria
[3] St Anna Childrens Hosp, Childrens Canc Res Inst, Vienna, Austria
[4] Univ Heidelberg, Univ Hosp Mannheim, Dept Dermatol Venereol & Allergy, Heidelberg, Germany
[5] Hokkaido Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 060, Japan
关键词
factor XIIIa; flow cytometry; laser scanning microscopy; M phi 2; placenta;
D O I
10.1046/j.8755-8920.2003.00128.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Problem: Depending on the type of their activation, macrophages may promote T(H)1- or T(H)2-type of immune responses. To date, not much is known about the activation phenotype of decidua macrophages, which-together with NK cells-constitute the majority of bone marrow derived cells at this location. Method of Study: The study was based on analysis of healthy first trimester decidua by immunohistochemistry and flow cytometry. We analyzed expression of markers characteristic for alternatively activated macrophages (Mphi2). Results: The markers MS-1 (stabilin-1) and coagulation factor XIIIa were found expressed in the interior of decidua macrophages (DMphi). In contrast, indoleamine 2,3-dioxygenase (IDO), an enzyme induced in macrophages by IFNgamma, was not present in DMphi. Conclusions: First trimester DMphi display phenotypic markers associated to alternatively activated macrophages. In addition, absence of IDO indicates that DMphi are not under a predominant influence of IFNgamma.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 36 条
[1]
Adány R, 2001, THROMB HAEMOSTASIS, V85, P845
[2]
Adany Roza, 1996, Seminars in Thrombosis and Hemostasis, V22, P399, DOI 10.1055/s-2007-999038
[3]
PLATELET VINCULIN - A SUBSTRATE OF ACTIVATED FACTOR-XIII [J].
ASIJEE, GM ;
MUSZBEK, L ;
KAPPELMAYER, J ;
POLGAR, J ;
HORVATH, A ;
STURK, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 954 (03) :303-308
[4]
Baines MG, 1997, AM J REPROD IMMUNOL, V37, P471
[5]
BULMER JN, 1995, IMMUNOLOGY HUMAN REP, P3131
[6]
INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY IN HUMAN MONONUCLEAR PHAGOCYTES [J].
CARLIN, JM ;
BORDEN, EC ;
SONDEL, PM ;
BYRNE, GI .
JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 45 (01) :29-34
[7]
FACTOR-XIIIA-CATALYZED CROSS-LINKING OF PLATELET AND MUSCLE ACTIN - REGULATION BY NUCLEOTIDES [J].
COHEN, I ;
BLANKENBERG, TA ;
BORDEN, D ;
KAHN, DR ;
VEIS, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 628 (03) :365-375
[8]
FIBRINOLIGASE-CATALYZED CROSS-LINKING OF MYOSIN FROM PLATELET AND SKELETAL-MUSCLE [J].
COHEN, I ;
YOUNGBANDALA, L ;
BLANKENBERG, TA ;
SIEFRING, GE ;
BRUNERLORAND, J .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1979, 192 (01) :100-111
[9]
Eis ALW, 1997, AM J REPROD IMMUNOL, V38, P289
[10]
FACTOR 13 DEFICIENCY WITH SEVERE HEMORRHAGIC DIATHESIS [J].
FISHER, S ;
RIKOVER, M ;
NAOR, S .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1966, 28 (01) :34-&